Growth Metrics

Cytosorbents (CTSO) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -62.83%
Dec 31, 2025 -34.56%
Sep 30, 2025 -22.15%
Jun 30, 2025 -20.34%
Mar 31, 2025 30.94%
Dec 31, 2024 -17.01%
Sep 30, 2024 -23.21%
Jun 30, 2024 -11.20%
Mar 31, 2024 -16.41%
Dec 31, 2023 24.82%
Sep 30, 2023 -23.09%
Jun 30, 2023 -18.30%
Mar 31, 2023 -15.37%
Dec 31, 2022 -9.62%
Sep 30, 2022 -17.70%
Jun 30, 2022 -14.20%
Mar 31, 2022 -11.43%
Dec 31, 2021 -11.38%
Sep 30, 2021 -5.07%
Jun 30, 2021 -3.72%
Mar 31, 2021 -2.47%
Dec 31, 2020 -1.27%
Sep 30, 2020 229.87%
Jun 30, 2020 14.12%
Mar 31, 2020 523.56%
Dec 31, 2019 -49.24%
Sep 30, 2019 -41.66%
Jun 30, 2019 -23.13%
Mar 31, 2019 -11.34%
Dec 31, 2018 -15.63%
Sep 30, 2018 -6.91%
Jun 30, 2018 49.24%
Mar 31, 2018 40.77%
Dec 31, 2017 8.33%
Sep 30, 2017 19.68%
Jun 30, 2017 604.00%
Mar 31, 2017 -217.43%
Dec 31, 2016 -2.99%
Sep 30, 2016 -64.62%
Jun 30, 2016 -37.79%
Mar 31, 2016 -36.39%
Dec 31, 2014 164.32%
Sep 30, 2014 -16.98%
Jun 30, 2014 -27.16%
Mar 31, 2014 49.12%
Dec 31, 2013 -4.81%
Sep 30, 2013 -3.23%
Jun 30, 2013 -10.46%
Mar 31, 2013 -2.68%
Dec 31, 2012 -1,074.87%
Sep 30, 2012 101.44%
Jun 30, 2012 10.59%
Mar 31, 2012 105.31%
Dec 31, 2011 -1,000.07%
Sep 30, 2011 -41.53%